Ftse Mib
34.492,41
0,13%
DAX
18.497,94
-0,09%
S&P 500
5.277,51
0,80%
NASDAQ
16.735,02
-0,01%
Bitcoin
67.763,75
0,42%
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Europa EU Onward Medical NV (ONWD) Onward Medical NV (ONWD) Notizie

ONWD

Onward Medical NV (ONWD)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:EU:ONWD
DataOraFonteTitoloSimboloCompagnia
24/05/202403:19GlobeNewswire Inc.ONWARD® Medical fait le point sur le premier trimestre 2024 et sur les faits marquants de l’année écouléeEU:ONWDOnward Medical NV
24/05/202403:19GlobeNewswire Inc.ONWARD® Medical berichtet über das 1. Quartal 2024 und die bisherigen Höhepunkte des JahresEU:ONWDOnward Medical NV
23/05/202407:30GlobeNewswire Inc.ONWARD® Medical Reports Q1 2024 Update and Year-to-Date HighlightsEU:ONWDOnward Medical NV
22/05/202419:13GlobeNewswire Inc.ONWARD® Medical organise une téléconférence pour partager les détails relatifs à son étude clinique Up-LIFT et à sa publication dans la revue Nature MedicineEU:ONWDOnward Medical NV
22/05/202419:13GlobeNewswire Inc.ONWARD® Medical veranstaltet Webcast zu Einzelheiten der Up-LIFT-Studie und der aktuellen Veröffentlichung in Nature MedicineEU:ONWDOnward Medical NV
21/05/202423:53GlobeNewswire Inc.Nature Medicine se réjouit de partager l’amélioration significative de la fonction de la main et du bras après une lésion de la moelle épinière grâce à la thérapie ONWARD® ARC-EX® TherapyEU:ONWDOnward Medical NV
21/05/202423:53GlobeNewswire Inc.Nature Medicine hebt signifikante Verbesserung der Hand- und Armfunktion nach einer Rückenmarksverletzung durch die ONWARD® ARC-EX® Therapie hervorEU:ONWDOnward Medical NV
21/05/202418:25GlobeNewswire Inc.ONWARD® Medical to Host Webcast to Share Details from its Up-LIFT Trial and Yesterday’s Nature Medicine PublicationEU:ONWDOnward Medical NV
20/05/202417:35GlobeNewswire Inc.Nature Medicine Highlights Significant Improvement in Hand and Arm Function After Spinal Cord Injury with Use of ONWARD® ARC-EX® TherapyEU:ONWDOnward Medical NV
16/05/202400:43GlobeNewswire Inc.ONWARD® Medical plant Webcast zur Vorstellung des Geschäftsverlaufs im 1. Quartal 2024EU:ONWDOnward Medical NV
16/05/202400:43GlobeNewswire Inc.ONWARD® Medical organise un webinaire pour présenter l’état des lieux de ses activités du premier trimestre 2024EU:ONWDOnward Medical NV
15/05/202400:21GlobeNewswire Inc.ONWARD® Medical Schedules Webcast to Provide Q1 2024 Business UpdateEU:ONWDOnward Medical NV
03/05/202403:31GlobeNewswire Inc.Avis de convocation à l’assemblée générale 2024 des actionnaires ONWARD® et propositions de résolutionsEU:ONWDOnward Medical NV
02/05/202407:00GlobeNewswire Inc.ONWARD® Medical Convocation of the 2024 Annual General Meeting of Shareholders and Proposed ResolutionsEU:ONWDOnward Medical NV
26/04/202415:17GlobeNewswire Inc.ONWARD® Medical annonce ses résultats financiers et opérationnels pour l’exercice 2023 et partage les faits qui ont marqué l’exercice 2024 à ce jourEU:ONWDOnward Medical NV
25/04/202407:30GlobeNewswire Inc.ONWARD® Medical Reports Full Year 2023 Financial and Operating Results and Shares 2024 Highlights Year-to-DateEU:ONWDOnward Medical NV
11/04/202407:30GlobeNewswire Inc.ONWARD® Medical Announces Publication of Full Year 2023 Financial Results and Business Update WebcastEU:ONWDOnward Medical NV
09/04/202407:00GlobeNewswire Inc.Stifel Initiates Research Coverage of ONWARD® Medical with a Buy Rating and Target Price of EUR 12.00EU:ONWDOnward Medical NV
02/04/202407:30GlobeNewswire Inc.ONWARD® Medical Submits De Novo Application to FDA for its ARC-EX® SystemEU:ONWDOnward Medical NV
25/03/202417:40GlobeNewswire Inc.ONWARD® Medical Publishes Closing of Accelerated Bookbuild Offering and Public Offering in FranceEU:ONWDOnward Medical NV
21/03/202418:26GlobeNewswire Inc.ONWARD® Medical Publishes Prospectus for Listing of New SharesEU:ONWDOnward Medical NV
21/03/202403:03GlobeNewswire Inc.ONWARD® Medical Lève avec Succès 20 millions d'euros dans le cadre d'une Augmentation de Capital par le biais d'une Procédure de Construction Accélérée d'un Livre d'Ordres et d'une Offre au Public en FranceEU:ONWDOnward Medical NV
21/03/202403:03GlobeNewswire Inc.ONWARD® Medical Successfully Raises €20 Million in a Capital Increase by Way of an Accelerated Bookbuild Offering and by Way of a Public Offering in FranceEU:ONWDOnward Medical NV
20/03/202418:29GlobeNewswire Inc.ONWARD® Medical Launches Capital Increase by Way of an Accelerated Bookbuild Offering and of a Public Offering in France for an Indicative Amount of EUR 15 Million, with an Up to EUR 5 Million Upsize OptionEU:ONWDOnward Medical NV
18/03/202407:30GlobeNewswire Inc.ONWARD® Medical Successfully Completes Benchmark Testing on Path to Commercialize ARC-EX® SystemEU:ONWDOnward Medical NV
15/03/202407:30GlobeNewswire Inc.ONWARD® Medical Reaffirms Guidance, Shares 2024 Strategic Priorities, and Releases Unaudited Q4 Financial HighlightsEU:ONWDOnward Medical NV
15/03/202407:30GlobeNewswire Inc.ONWARD verstärkt Führungsteam auf Schlüsselpositionen in den Bereichen Clinical & Regulatory sowie MarketingEU:ONWDOnward Medical NV
15/03/202407:30GlobeNewswire Inc.ONWARD renforce son management avec des nominations clés dans le domaine clinique et réglementaire et en marketingEU:ONWDOnward Medical NV
11/03/202407:30GlobeNewswire Inc.ONWARD® Medical Accepted to New US FDA TAP Program for Development of its ARC-BCI™ SystemEU:ONWDOnward Medical NV
29/02/202407:41GlobeNewswire Inc.ONWARD® Medical Awarded 10th Breakthrough Device Designation for Brain-Computer Interface (BCI) from US FDAEU:ONWDOnward Medical NV
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:EU:ONWD

La tua Cronologia

ASX
EMPDD
Emperor Energy
BIT
S29358
Societe Generale Effekten
BOV
TKNO4F
TEKNO PN
LSE
85FV
Sg Issuer 27
COIN
ROBOTETH
MetaFactory
AMEX
GQN
LSE
PKPH
USOTC
TELIF
Telescope Innovations (QB)
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network